Merit Financial Group’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.15M Buy
33,708
+1,209
+4% +$185K 0.04% 385
2025
Q4
$4.48M Buy
32,499
+1,354
+4% +$177K 0.04% 383
2025
Q3
$3.99M Buy
31,145
+625
+2% +$76.3K 0.04% 362
2025
Q2
$3.69M Buy
30,520
+10,542
+53% +$1.19M 0.04% 348
2025
Q1
$2.23M Buy
19,978
+9,187
+85% +$978K 0.03% 391
2024
Q4
$1.05M Buy
10,791
+1,010
+10% +$108K 0.02% 494
2024
Q3
$1.13M Sell
9,781
-827
-8% -$93.8K 0.03% 395
2024
Q2
$1.13M Buy
10,608
+93
+0.9% +$9.34K 0.02% 378
2024
Q1
$1.02M Buy
10,515
+8,509
+424% +$872K 0.02% 400
2023
Q4
$203K Buy
+2,006
New +$194K 0.01% 726

Other funds holding NVS